Udg Healthcare PLC (LON:UDG) had its price target lifted by analysts at Berenberg Bank from GBX 655 ($8.55) to GBX 700 ($9.14) in a note issued to investors on Friday. The firm currently has a “buy” rating on the stock. Berenberg Bank’s price objective would indicate a potential upside of 10.41% from the stock’s previous close.

Several other research firms also recently weighed in on UDG. Numis Securities Ltd reiterated an “add” rating and set a GBX 675 ($8.81) target price on shares of Udg Healthcare PLC in a research report on Thursday, August 4th. Jefferies Group increased their target price on Udg Healthcare PLC from GBX 630 ($8.22) to GBX 680 ($8.88) and gave the stock a “buy” rating in a research report on Tuesday, July 26th. Davy Research reiterated an “outperform” rating on shares of Udg Healthcare PLC in a research report on Thursday, August 4th. Goodbody restated a “buy” rating on shares of Udg Healthcare PLC in a research note on Thursday, August 4th. Finally, Stifel Nicolaus restated a “hold” rating and set a GBX 620 ($8.09) price target on shares of Udg Healthcare PLC in a research note on Wednesday, September 28th. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of GBX 666 ($8.69).

Analyst Recommendations for Udg Healthcare PLC (LON:UDG)

Udg Healthcare PLC (LON:UDG) traded down 1.93% during midday trading on Friday, reaching GBX 634.00. The company had a trading volume of 411,585 shares. The firm’s market capitalization is GBX 1.56 billion. Udg Healthcare PLC has a 12 month low of GBX 452.20 and a 12 month high of GBX 663.00. The firm’s 50-day moving average price is GBX 632.06 and its 200 day moving average price is GBX 603.04.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/07/udg-healthcare-plc-udg-pt-raised-to-gbx-700-at-berenberg-bank.html

In other news, insider Chris Corbin sold 90,849 shares of the stock in a transaction dated Monday, September 26th. The stock was sold at an average price of GBX 634 ($8.28), for a total value of £575,982.66 ($751,837.44).

About Udg Healthcare PLC

UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies in approximately 20 countries.

Receive News & Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related companies with MarketBeat.com's FREE daily email newsletter.